Wyeth and FDA warn professionals about Effexor

Share this article:
Wyeth and the FDA are warning healthcare professionals about an overdose potential for patients taking the antidepressant Effexor. A labeling change states that overdose has occurred predominantly in combination with alcohol and/or other drugs.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.